A detailed history of Catalyst Financial Partners LLC transactions in Incyte Corp stock. As of the latest transaction made, Catalyst Financial Partners LLC holds 7,293 shares of INCY stock, worth $502,050. This represents 0.09% of its overall portfolio holdings.

Number of Shares
7,293
Previous 7,299 0.08%
Holding current value
$502,050
Previous $442 Million 8.95%
% of portfolio
0.09%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$57.33 - $68.61 $343 - $411
-6 Reduced 0.08%
7,293 $482 Million
Q2 2024

Jul 25, 2024

BUY
$51.18 - $63.75 $373,562 - $465,311
7,299 New
7,299 $442 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Catalyst Financial Partners LLC Portfolio

Follow Catalyst Financial Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Financial Partners LLC with notifications on news.